Table Of Content

AUTHOR INDEX (P = proceedings) AARONS, L. see YOUNG, M.A. ANDREASEN, F. see SONNE, J. pharmacokinetics of nisoldipine in ABATE, M.A., NEELY, J.L., LAYNE, ANGELO, H.R. see BONDE, J. elderly and young subjects, 367 R.D. & D’ALESSANDRI, R. ANGUS, P.W. see CHING, M.S. BALDERSON, D.E., HARRON, Interaction of indomethacin and AOGAICHI, K. see MASSARELLA, D.W.G., ESCALONA, O. & sulindac with labetalol, 363 J.W. MITCHELL, R.H. A comparison of ABBATE, R. see MODESTI, P.A. ARCHIBALD, M.P. see McDOWELL, the incidence and reproducibility ABRAMS, S.M.L. see LLEDO, P. J.F.W. of ventricular late potentials (LP) ADAIR, C.G. see McCALLION, ARENDT-NIELSEN, L. see NIELSEN, in the time and frequency domain O.N.M. ne. in patients with cardiovascular AHR, G. se2 BAKSI, A.K. ARIAS, T.D., JORGE, L.F. & (CV) disease, 244P AHSAN, C.H., CHALLENOR, V.F., BARRANTES, R. Letter to the BALDERSON, D.E., HARRON, DANIELS, R., RENWICK, A.G. & Editors: Uses and misuses of D.W.G., MITCHELL, R.H. & WALLER, D.G. The influence of definitions of genetic ESCALONA, O. Evaluation of posture on the pharmacokinetics polymorphism. A perspective from ventricular late potentials in the of nifedipine, 564P population pharmacogenetics, 117 frequency domain at various AHSAN, C.H., RENWICK, A.G., ARNOLD, B.D.C. see ALLEN, A. bandwiths, 583P MACKLIN, B., CHALLENOR, V.F., ARNOLD, J.M.O., MACLEOD, A.P., BALLARDIE, F.W. see EDWARDS, WALLER, D.G. & GEORGE, C.F. Lul, A.S., BROWN, J.E., B.D. Ethnic differences in the FELDMAN, R.D. & KOSTUK, W.J. BAMMEL, A., MONIG, H., ZURBORN, pharmacokinetics of oral a- and B-adrenoceptor mediated K.H., OHNHAUS, E.E. & KIRCH, nifedipine, 399 venous responsiveness of dorsal W. Letter to the Editors: Enzyme- AIRD, S. A., BELK, D., BENNETT, hand veins in patients with severe inducing properties of probenecid J.P., HUMPHRIES, S.J., heart failure, 222P in man, 120 NOTARIANNI, L.J. & BENNETT, ARONSON, J.K. see MORAES, M.E.A. BANJAR, W.M.A. see AL-EITHAN, P.N. The relative importance of ASHFORD, J.J. see WRIGHT, S. M. factors affecting the passage of ASHTON, C.H. see EDWARDS, C. BARBER, H.E. see BOATENG, Y.A. drugs into human breast milk, ATANGA, G.K. see FOSTER, R.W. BARNES, N.M., GE, J., JONES, 593P ATTALI, P. see MAGUEUR, E. W.G., NAYLOR, R.J. & RUDD, AIRD, S.A. see OLIVER, S.E. AYESH, R., KROEMER, H., J.A. Changes in plasma 5-HT AKITA, H. see SAKAI, H. EICHELBAUM, M. & SMITH, R.L. levels during cisplatin treatment in AL-EITHAN, M., BANJAR, W.M.A., Metabolism of verapamil in a man, 235P GAZZAZ, J., BRADSHAW, C.M. & family pedigree with deficient N- BARNES, P.J. see EVANS, P.M. SZABADI, E. Effects of high oxidation of trimethylamine, 693 BARNETT, D.B. see SCOTT, R.A. ambient temperature and BARRANTES, R. see ARIAS, T.D. terbutaline on physiological BABER, N.S. The scope of clinical BARRE, J. see DUCHE, J-C. tremor, 603P pharmacology in the BARRY, M.G. MACMATHUNA, P., ALLAIN, P., MAURAS, Y., PREMEL- pharmaceutical industry, 495 YOUNGER, K., KEELING, P.W.N. CABIC, A., ISLAM, S., HERVE, BACK, D.J. see ORME, M. & FEELY, J. Effect of zinc J.P. & CLEDES, J. Effects of BACK, D.J., SIM, S.M. & supplementation on oxidative drug EDTA infusion on the urinary BRECKENRIDGE, A.M. Effect of metabolism in patients with elimination of several elements in various drugs on the hepatic cirrhosis, 488 healthy subjects, 347 glucuronidation of zidovudine in BATEMAN, D.N., LEE, A., RAWLINS, ALLEN, A., ARNOLD, B.D.C., human liver microsomes, 594P M.D. & SMITH, J.M. DAVIE, C.C. & ZUSSMAN, B.D. BACK, D.J. see TWA, J.F. Geographical differences in The oral pharmacokinetics of BRL BAINBRIDGE, A.D., ELLIOTT, H.L. adverse drug reaction reporting 46470, a healthy selective 5-HT & REID, J.L. The interaction rates in the Northern region, 188 receptor antagonist, in healthy between the a-adrenoceptor BEASTALL, G.H. see LARKIN, J.G. male subjects, 604P antagonist doxazosin and the BECHTEL, P. see DUCHE, J-C. ALVAN, G., HAMMARLUND- angiotensin converting enzyme BECK, S.C. see PERUCCA, E. UDENAES, M. & ODLIND, B. inhibitor enalapril, 569P BEIER, H. see DE BOER, A. Letter to the Editors: The validity BAINBRIDGE, A.D. see MACFADYEN, BEKHECHI, D. see UZZAN, B. of the sigmoid E,,,, model and Rev. BELCH, J.J. see LANG, C.C. efficiency concept in diuretic BAINBRIDGE, A.D., MACFADYEN, BELK, D. see AIRD, S.A. studies, 210 R.J., LEES, K.R. & REID, J.L. BELK, D. see OLIVER, S.E. ALVAN, G., KARLSSON, K.K., A study of the acute BELL, P. see KING, D.J. HELLGREN, U. & VILLEN, Y. pharmacodynamic interaction of BELLISSANT, E. see THUILLEZ, C. Hearing impairment related to ramipril and felodipine in BELZ, G.G. see KLEINBLOESEM, plasma quinine concentration in normotensive subjects, 148 Ci. healthy volunteers, 409 BAKER, D., ROBERTS, D.E., BELZ, G.G. see SCHMITT, R. AMOR, B. see KAHAN, A. NEWCOMBE, R.G. & Fox, BENET, L.Z. see GUMBLETON, M. ANDERSSON, T., BERGSTRAND, R. & K.A.A. Evaluation of drug BENITO-ORFILA, M.A., PLAYFORD, CEDERBERG, C. Influence of acid information for cardiology R.J., NANDHA, K.A., secretory status on absorption of patients, 525 NIHOYANNOPOULOUS, P., DOMIN, omeprazole from enteric coated BAKSI, A.K., EDWARDS, J.S. & J., TATEMOTO, K., BLOOM, S.R. granules, 275 AHR, G. A comparison of the & CALAM, J. Postprandial 725 726 Index concentrations of peptide YY BowEsS, S.G. see DOBBS, R.J. SCHIPPER, J., BREIMER, D.D. & (PYY) induce changes on Boye, N.P. see MELLEM, H. COHEN, A.F. Comparison of vasoactive intestinal peptide (VIP) BRADSHAW, C.M. see AL-EITHAN, duplex scanning and venous cardiovascuiar response, 613P M. occlusion plethysmography in the BENNETT, A. see RILEY, S.A. BRADSHAW, C.M. see FLEMING, assessment of the reactivity of the BENNETT, J.P. see AIRD, S.A. PF.J. forearm venous system in man, BENNETT, P.N. see OLIVER, S.E. BRADSHAW, C.M. see FLETT, S.R. 584P BENRIMOJ, S.I. see CHUA, S.S. BRADSHAW, C.M. see LISTER, B.S. BuRNS, J.M.A. see GEMMILL, J.D. BERDEAUX, A. see UZZAN, B. BRADSHAW, C.M. see MORLEY, M.J. BURTON, L.C., GOING, T.C. & BERGER, A. see DAVEY, N.B. BRAMLEY, K.W. see GOUDIE, A.W. VERE, D.W. Nefopam antagonises BERGSTRAND, R. see ANDERSSON, T. BRANNIGAN, P. see JAMISON, J.P. nociception for electrical pain in BERTOLINE, M.A. see SANTOS, S.R. BRAWN, L.A. see TONER, J.M. the lower but not the upper digits, BEST, S.J. see KING, D.J. BRAWN, L.A., TONER, J.M., YEO, 602P BEVAN, E.G., CURRIE, E.M., W.W. & RAMSAY, L.E. BurRY, R.W. see MOULDS, R.F.W. MCGHEE, S.M. & MCINNES, G.T. Adequacy of twice daily dosing BUSHNELL, J.L. see EDWARDS, C. Patient knowledge about diuretic with potassium chloride and BYTH, W. see KING, D.J. prescription, 610P spironolactone in thiazide treated BIRKETT, D.J. & MINERS, J.O. hypertensive patients, 227P CALAM, J. see BENITO-ORFILA, M.A. Caffeine rena: clearance and urine BRECKENRIDGE, A. Clinical CALVER, A.L., COLLIER, J.G. & caffeine concentration during pharmacology in the United VALLANCE, P.J.T. Response to steady state dosing. Implications Kingdo—ma view for the 1990s, local intra-arterial infusions of L- for monitoring caffeine intake 249 and p-arginine in the human during sports events, 495 BRECKENRIDGE, A.M. see BACK, forearm, 576P BIRKETT, D.J. see DOECKE, C.J. D.J: CAMBIUCCI, E.C. see CONDINO- BJERRING, P. see NIELSEN, J.C. BRECKENRIDGE, A.M. see NETO, A. BLACK, D.J. see WILD, M.J. PIRMOHAMED, M. CAMPBELL, A.C., MCELNAY, J.C. & BLACKETT, A. & TURNER, P. The BRECKENRIDGE, A.M. see WARD, PASSMORE, C.M. The excretion of use of the apparent fragment S.A. ampicillin in breast milk and its constant f’ to predict the buccal BREDESEN, J.E. see GJESDAL, K. effect on the suckling infant, 230P absorption and hence the renal BREIL, I. see STEINFATH, M. CAMPBELL, N.R.C. & HASINOFF, excretion of basic drugs, 232P BREIMER, D.D. see BURGGRAAF, J. B.B. Iron supplements: a common BLASCHKE, T.F. see FORD, G.A. BREIMER, D.D. see PIETERS, M.S.M. cause of drug interactions, 251 BLOMFIELD, I.A. see GOUDIE, A.W. BREIMER, D.D. see SCHELLENS, CAMPBELL, N.R.C. see KARA, M. BLOMOVIST, M. see KING, D.J. J.H.M. ° CAPACCI, L. see SANTOS, S.R. BLooM, S.R. see BENITO-ORFILA, BREIMER, D.D. see SOONS, P.A. CAPEWELL, A. see CAPEWELL, S. M.A. BREIMER, D.D. see VAN CAPEWELL, S. & CAPEWELL, A. BLOUIN, R.A. see ZHANG, Y. STEVENINCK, A.L. ‘First dose’ hypotension and BLYCHERT, E. see GOUDIE, A.W. BREWSTER, D. see SEYMOUR, R.A. venodilatation, 213 BOATENG, Y.A., BARBER, H.E.., BROCHARD, P. see DUCHE, J-C. CARABINE, U.A., WRIGHT, P.M.C. MACDONALD, T.M., PETRIE, J.C. BROCKMEYER, N.H., PASCHELKE, & Moore, J. Preanaesthetic & LEE, M.R. Disposition of y- S., SCHERBAUM, N., MERTINS, L., medication: a comparison of three glutamyl levodopa (gludopa) after DAECKE, C. & Goos, M. Effect doses of oral clonidine with intravenous bolus injection in of antipsoriatic therapy (selective temazepam, 240P healthy volunteers, 419 u.v. phototherapy, sup, anthralin, CARPENTER, J.R. see FOSTER, R.W. BOCHNER, F. see CHEN, Z.R. etretinate, methoxypsoralene + CECIONI, I. see MODESTI, P.A. BOCHNER, F. see EVANS, A.M. UVA) on the cytochrome P450 CEDERBERG, C. see ANDERSSON, T. BOESGAARD, S. see SONNE, J. monooxygenase enzyme system, CHADWICK, D.C. see PIRMOHAMED, BOLOFO, M-L. see GRAY, S.J. 567P M. BONDE, J., PEDERSEN, L.E.., BRODIE, M.J. see LARKIN, J.G. CHALLENOR, V.F. see AHSAN, C.H. NYGAARD, E., RAMSING, T., BRODIE, M.J. see THOMSON, G.D. CHALLENOR, V.F., WALLER, D.G., ANGELO, H.R. & KAMPMANN, BROOKS, N.H. see SCHOFIELD, P.M. HAYWARD, R.A., GRIFFIN, M.J. J.P. Stereoselective BRQ@SEN, K. see WARD, S.A. & ROATH, O.S. Subjective and pharmacokinetics of disopyramide BROWN, J.E. see ARNOLD, J.M.O. objective assessment of enalapril and interaction with cimetidine, BROWN, M.J. & DICKERSON, C. in primary Raynaud’s 708 Synergistic effect of a- phenomenon, 477 Boosis, A.R. see JACKSON, P.R. adrenoceptor blockade and ACE CHALMERS, R.J. see EDWARDS, B.D. Bootu, N. see GEMMILL, J.D. inhibition in hypertension, 568P CHAN, J.C.N., CRITCHLEY, J.A.J.H., BORNER, M. see FATTINGER, K. BUHRER, M., FREY, F.J. & FREY, COCKRAM, C.S., Ho, C.S., BOUTAGY, J.S. see PAGE, M.A. B.M. Prednisolone concentrations NICHOLLS, M.G. & Bowes, S.G., CLARK, P.K., in cerebrospinal fluid after SWAMINATHAN, R. Urinary CHARLETT, A., O’NEILL, C.J.A., different prednisolone prodrugs, sodium and dopamine relations in LEEMAN, A.L., WELLER, C., 111 Chinese hypertensive type 2 (non- NICHOLSON, P.W., DESHMUKH, BULLMAN, J.N., DAVIES, B.E., insulin-dependent) diabetic A.A., DOBBS, S.M. & DOBBs, GILL, T.S:, TAYLOR; A:C., patients with and without R.J. Objective outcome criteria in KAYE, C.M. & WILLIAMS, A.J. nephropathy, 573P trials of anti-Parkinsonism therapy The pharmacokinetics of BRL CHAN, T.Y.K., CRITCHLEY, in the elderly: sensitivity, 38227 in healthy male volunteers, J.A.J.H., WONG, W.K.K., Ho, specificity and reliability of 590P C.S. & SWAMINATHAN, R. measures of brady- and hypo- BUNNAG, D. see KARBWANG, J. Urinary dopamine, noradrenaline, kinesia, 295 BURGGRAAF, J., v.d. BERG, R., adrenaline and sodium Index 727 relationships in hypertensive and COHEN, A.F. see DE BOER, A. D’ALESSANDRI, R. see ABATE, M.A. normotensive Chinese with or COHEN, A.F. see HENNEN, J. DAECKE, C. see BROCKMEYER, N.H. without a family history of COHEN, A.F. see KROON, C. DAHLSTROM, B. see GRAHNEN, A. hypertension, 218P COHEN, A.F., KROON, R., DALPHIN, J.C. see DUCHE, J-C. CHAN, T.Y.K. see TOMLINSON, B. SCHOEMAKER, H.C., DANIELS, R. see AHSAN, C.H. CHARLETT, A. see BOWES, S.G. HOOGKAMER, J.F.W. & VAN DASHWOOD, M.R., COLLINS, M.J., CHARLETT, A. see DosBs, R.J. VLIET-VERBEEK, A. Effects of SYKES, R.M.., CHAUSSADE, S. see KAHAN, A. gastric acidity on the THEODOROPOULOUS, S., PREHAR, CHEN, S-S. see SHEN, M-R. bioavailability of digoxin. S. & YAcouB, M.H. ['*°I]- CHEN, Z.R., SOMOGYI, A.A.., Evidence for a new mechanism for endothelin-1 binding to human REYNOLDS, G. & BOCHNER, F. interactions with omeprazole, coronary arteries and bypass Disposition and metabolism of 565P grafts: an autoradiographic study, codeine after single and chronic COHEN, A.F. see PIETERS, M.S.M. 585P doses in one poor and seven COHEN, A.F. see VAN GRIENSVEN, DAVEY, N.B., CHIMA, P., BERGER, extensive metabolisers, 381 J.M.T. A., LEE, P.S., MORGAN, C.J.L., CHIANG, P-H. see SHEN, M-R. COHEN, A.F. see VAN STEVENINCK, GRUNDY, P.F., DAWES, M., CHIMA, P. see DAVEY, N.B. A.L. WATSON, D.G., ROGER, R.A., CHING, M.S., LENNARD, M.S., COLELLA, A. see MODESTI, P.A. SVENSSON, M., COMPTON-PIERCE, TUCKER, G.T., Woops, H.F., COLEMAN, D.C. see GALLAGHER, V., RICHARDSON, P.D.I. & KEtLy, D.E. & KELLY, S.L. Pah TIMERICK, S.J.B. Genetic expression of human COLEMAN, M.D. see PIRMOHAMED, Antihypertensive effect of a fixed cytochrome P450IA1 in the yeast M. combination of felodipine and Saccharomyces cerevisiae, 595P COLEMAN, M.D. see TINGLE, M.D. metoprolol in a new extended CHING, M.S., MIHALY, G. W., COLEMAN, M.D., TINGLE, M.D. & release formulation, 246P ANGUS, P.W., MORGAN, D.J., PARK, B.K. Inhibition of dapsone- DAVIE, B.E. see PEPPIATT, J.E. DEVENISH-MEARES, S., induced methaemoglobinaemia DAVIE, C.C. see ALLEN, A. YEOMANS, N.D. & SMALLWOOD, during chronic dapsone DAVIES, B.E. see BULLMAN, J.N. R.A. Oral bioavailability of administration in the rat, 232P DAVIES, B.E. see HUCKER, R.S. omeprazole before and after COLLIER, J.G. see CALVER, A.L. DAWES, M. see DAVEY, N.B. chronic therapy in patients with COLLIER, J.G. & HERXHEIMER, A. DAWKINS, K.D. see DONALDSON, duodenal ulcer, 166 The roles and responsibilities of K.M. CHONGSUPHAJAISIDDHI, T. see Clinical Pharmacology, 495 DAWLING, S. see WRIGHT, S. NOSTEN, F. COLLIER, J.G. see VALLANCE, P.J.T. DE BOER, A., KLUFT, C., GERLOFF, CHOPRA, M. see MCMURRAY, J. COLLINS, A.J. see JONES, R.W. J., DOOIJEWAARD, G., GUNZLER, CHOUDRY, N.B., MCEWAN, J.R., COLLINS, M.J. see DASHWOOD, M.R. W.A., BEIER, H. & COHEN, A.F. LAVENDER, E.A., WILLIAMS, COMPTON-PIERCE, V. see DAVEY, Pharmacokinetics and A.J. & FULLER, R.W. Human N.B. pharmacodynamics of the responses to inhaled capsaicin are CONDINO-NETO, A., VILELA, recombinant pro-urokinase not inhibited by granisetron, 337 M.M.S., CAMBIUCCI, E.C., saruplase, 584P CHRISTENSEN, H.R. see JORGENSEN, RIBEIRO, J.D., GIANNI, A.A.G., DE Boer, A. see KROON, C. HS. MaGna, L.A. & DE Nucci, G. DE CREMOUX, H. see DUCHE, J-C. CHRYSTYN, H. see MCALEER, S.D. Theophylline therapy inhibits DE Nuccl, G. see CONDINO-NETO, CHUA, S.S., BENRIMOJ, S.I., neutrophil and monocyte A. GORDON, R.D. & WILLIAMS, G. chemotaxis in chronic asthmatic DEFEO, T.M. see MASSARELLA, J.W. Cardiovascular effects of a children, 576P DELLENBACH, M. see chloropheniramine/paracetamol COOKE, T. see O’CONNOR, P. KLEINBLOESEM, C.H. combination in hypertensive CoopeER, S.J. see KING, D.J. DELLENBACH, M. see VAN patients who were sensitive to the COPELAND, S. see PASSMORE, A.P. GRIENSVEN, J.M.T. pressor effect of pseudoephedrine, CORRIGAN, O.I. see HENMAN, M.C. DENNIS, M.J. see SALAS, I.G. 360 COUNIHAN, P. see FASHOLA, T.O.A. DEPIERRE, A. see DUCHE, J-C. CHUNG, K.F. see EVANS, P.M. COUTURIER, D. see KAHAN, A. DERENNE, F. see HERCHUELZ, A. CLARK, P.K. see BOWES, S.G. Cox, J.P., O’MALLEY, K. & DESHMUKH, A.A. see BOWES, S.G. CLARKE, J.G. see COCKCROFT, J.R. O'BRIEN, E. Does placebo lower DEsIR, D. see NYBERG, G.F. CLARKE, R.S.J. see MCCLUNE, S. ambulatory blood pressure DeVAULT, A.R. see PAN, H.Y. CLARKE, R.S.J. see MCLOUGHLIN, measured non-invasively?, 247P DEVENISH-MEARES, S. see CHING, Ci€; CRITCHLEY, J.A.J.H. see CHAN, M.S. CLEDES, J. see ALLAIN, P. EG.N: DICKERSON, C. see BROWN, M.J. COAKLEY, D. see MCCORMACK, CRITCHLEY, J.A.J.H. see CHAN, DICKINSON, R.G.; VERBEEK, R.K., P.M.E. TYR. KING, A.R., RESIFO, A.C. & COAKLEY, D. see MULPETER, K. CRITCHLEY, J.A.J.H. see POND, S.M. Diflunisal and its COATES, P.E. see THAM, T.C.K. TOMLINSON, B. conjugates in patients with renal CoBBE, S.M. see SEDGWICK, M. CROME, R., MANN, T.A.N., failure, 546 COCKCROFT, J.R., CLARKE, J.G. & MCCLELLAND, G.R. & VAN Doss, R.J. see BOWES. S.G. WEBB, D.J. The effect of intra- BRUMMELEN, P. Doss, R.J., LUBEL, D., CHARLETT, arterial endothelin on resting Pharmacodynamic response to A., BOWES, S.G., O'NEILL, blood flow and sympathetically subcutaneous administration of C.J.A., WELLER, C. & DOBBS, mediated vasoconstriction in the isoprenaline in healthy volunteers, S.M. Could free walking speed forearm of man, 521 242P reflect striatal dopamine, 606P COCKRAM, C.S. see CHAN, J.C.N. CULLEN, M.J. see HAYNES, W.G. Dosss, S.M. see BOWES, S.G. COHEN, A.F. see BURGGRAAF, J. CURRIE, E.M. see BEVAN, E.G. Dosss, S.M. see Doss, R.J. 728 Index DOECKE, C.J., VERONESE, M.E., nephrotoxicity in the normal function in heart transplant POND, S.M., MINERS, J.O., human kidney, 247P recipients, 236P BIRKETT, D.J., SANSOM, L.N. & EDWARDS, C., BUSHNELL, J.L., FATTINGER, K., VOZEH, S., HA, McManus, M.E. Relationship ASHTON, C.H. & RAWLINS, M.D. H.R., BORNER, M. & FOLLATH, between phenytoin and Hospital prescribing and usage of F. Population pharmacokinetics of tolbutamide hydroxylation in hypnotics and anxiolytics, 190 quinidine, 279 human liver microsomes, 125 EDWARDS, C., KAMALI, F. & FEARS, R. see GEMMILL, J.D. DOHERTY, M.M. see KING, D.J. RAWLINS, M.D. Lack of a FEELY, J. see BARRY, M.G. DomIN, J. see BENITO-ORFILA, M.A. pharmacokinetic interaction FEELY, J. & GRIMM, TI. DONALDSON, K.M., DAWKINS, K.D. between flosequinan and A comparison of drug protein & WALLER, D.G. The acute theophylline, 613P binding and a@,-acid glycoprotein haemodynamic effects of EDWARDS, G. see KARBWANG, J. concentration in Chinese and nisoldipine and nifedipine during EDWARDS, G., MANSOR, S.M., Caucasians, 551 treatment with atenolol, 579P MOLYNEAUX, M.E., WARD, S.A., FEELY, J. see MCCORMACK, P.M.E. DONEGAN, C. see MCCORMACK, TAYLOR, T.E. & WIRIMA, J.J. FEELY, J. see MULPETER, K. P.M.E. Effect of malaria infection on the FEELY, J. see O’CONNOR, P. DONNELLY, R., ELLIOTT, H.L., plasma concentration of a,-acid FEELY, J. see SHARMA, S.C. MEREDITH, P.A. & REID, J.L. glycoprotein and the binding of FEELY, M. see MCALEER, S.D. Dynamic and kinetic interactions quinine in Malawian children, FEHER, M.D. & LANT, A. F. Drug of nifedipine and doxazosin in 592P choices in the treatment of essential hypertension, 572P EDWARDS, J.S. see BAKSI, A.K. hypertension with coexistant DONNELLY, R. see MEREDITH, P.A. EICHELBAUM, M. see AYESH, R. hypercholesterolaemia by primary DONNELLY, R., MEREDITH, P.A. & EICHELBAUM, M. see MIKUS, G. care physicians in England, 609P ELLIoTT, H.L. The description EIDE, I. see MELLEM, H. FELDMAN, R.D. see ARNOLD, and prediction of antihypertensive EKHOLT, P.F. see MELLEM, H. J.M.O. drug response: an individualised ELLIOTT, H.L. see BAINBRIDGE, FELGATE, L. see FRAZER, N.M. approach, 627 ALD. FELL, G.L. see LEIGH, T.J. DOOIJEWAARD, G. see BOER, A. ELLIOTT, H.L. see DONNELLY, FELL, G.L. see LINK, C.G.G. DOSSING, M. see SONNE, J. R. FENWICK, M. see MOTWANI, J.G. DOUCHAMPS, J. see HERCHUELZ, A. ELLIOTT, H.L. see FERNER, R.E. Book review: DRENT-BREMER, A. see GIRBES, MACDONALD, N.J. Methodological Errors in A.R.J. ELLioTT, H.L. see MEREDITH, P.A. Research, 123 DREWE, J., MEIER, R., TIMONEN, ELLMERS, S.E., PARKER, L.R.C., FERNER, R.E., KAMALI, F. & U., THUMSHIRN, M., MUNZER, J., NOTARIANNI, L.J. & JONES, R.W. RAWLINS, M.D. The effects of KISSEL, T. & GyR, K. Excretion of paracetamol in fit and enalapril and sulindac on the Pharmacokinetics and frail elderly people, 596P dermal response to substance P pharmacodynamics of a new EPSTEIN, M.M., NELSON, S.D., and neurokinin, 114 transdermal delivery system for SLATTERY, J.T., KALHORN, T.F., FERRANDO, C. see HENMAN, M.C. bopindolol, 671 WALL, R.A. & WRIGHT, J.M. FERRES, H. see GEMMILL, J.D. DUCHE, J-C., JOANNE, C., BARRE, Inhibition of the metabolism of FILE, S.E. see EASTON, P. J., DE CREMOUX, H., DALPHIN, paracetamol by isoniazid, 139 FISCHER, C. see MIKUS, G. J.C., DEPIERRE, A., BROCHARD, ESCALONA, O. see BALDERSON, D.E. FITZGERALD, D.L. see LEwis, L.D. P., TILLEMENT, J.P. & BECHTEL, ETIENNE, J.P. see MAGUEUR, E. FLEMING, J.S. see OLIVER, R.M. P. Lack of a relationship between EVANS, A.M., NATION, R.L., FLEMING, J.S. see WALLER, D.G. the polymorphism of debrisoquine SANSOM, L.N., BOCHNER, F. & FLEMING, P.F.J., LODWICK, J., oxidation and lung cancer, 533 SomoGylI, A.A. Effect of racemic BRADSHAW, C.M. & SZABADI, E. DUNDEE, J.W. see MCMILLAN, C.M. ibuprofen dose on the magnitude Failure of clonidine to affect DUNDEE, J.W., YANG, J., and duration of platelet cyclo- physiological tremor in healthy MCMILLAN, C. & MADHI, A. oxygenase inhibition: relationship volunteers, 603P Some factors influencing cancer between inhibition of FLETT, S.R., SZABADI, E. & therapy chemotherapy sickness, thromboxane production and the BRADSHAW, C.M. Comparison of 601P plasma unbound concentration of fluvoxamine and amitriptyline on DUNN, F.G. see GEMMILL, J.D. S(+)-ibuprofen, 131 autonomic functions in healthy DURNIN, C. see LEwIs, R. EVANS, D.E. see FOSTER, R.W. volunteers, 604P EVANS, P.M., O’CONNOR, B.J., FOLLATH, F. see FATTINGER, K. FULLER, R.W., CHUNG, K.F. & FORD, G.A., BLASCHKE, T.F., EADIE, M.J. see HOOPER, W.D. BARNES, P.J. Effect of inhaled VESTAL, R.E. & HOFFMAN, B.B. EASTON, P., FILE, S.E. & budesonide on eosinophil density Adenosine mediated SKELLY, A.M. Mood changes in asthma, 616P venodilatation in young and and amnesia for dental procedures elderly men, 586P following treatment with nitrous FORREST, G. see LARKIN, J.G. oxide or midazolam, 602P FAHRNER, E. see KLEINBLOESEM, FOSTER, G., YEO, W.W. & RAMSAY. ECKERNAS, S.-A. see GRAHNEN, A. Ci: L.E. Effect of sulindac on the EDWARDS, B.D., TESTA, H.J., FAHRNER, E. see VAN GRIENSVEN, cough reflex of healthy subjects, LAwsON, R.S., CHALMERS, J.M.T. 207 R.J., O’DRISCOLL, J. & FASHOLA, T. see MILLANE, T.A. FOSTER, R.W., ATANGA, G.K.., BALLARDIE, F.W. The effects FASHOLA, T.O.A., JOHNSTON, A., CARPENTER, J.R., EVANS, D.E., of nifedipine on the COUNIHAN, P., PEPPER, J.R. & RAKSHI, K. & SMALL, R.C. haemodynamics and vasoactive HOLT, D.W. Blood cyclosporin A method for bioassay of potency regulation of cyclosporin absorption profiles and renal and effectiveness of inhaled Index 729 bronchodilators in normal bioavailability during exercise HAMILTON, B.A. see MCCALLION, subjects, 445 increases transiently after the daily O.N.M. FOWLER, G. see JAMIESON, M.J. change of patch, 561 HAMMARLUND-UDENAES, M. see Fox, K.A.A. see BAKER, D. GOH, E.M.L. see YOUNG, I.S. ALVAN, G. FRASER, G.C. see WHEELDON, N.M. GOING, T.C. see BURTON, L.C. HANRATH, P. see STEINFATH, M. FRAZER, N.M., FELGATE, L., Goos, M. see BROCKMEYER, N.H. HARPER, P.G. see LEwIs, L.D. KEERY, R.J. & KEENE, O.N. GORDON, R.D. see CHUA, S.S. HARRON, D.W.G. see BALDERSON, Tolerability of intravenous dosing Gott, D.M. see SALAS, I.G. D.E. of ondansetron 16 mg, 235P GOUDIE, A.W., GUPTA, O.M.., HARRON, D.W.G., MCMAHON, FREITAG, B. see KAHAN, A. GRAY, P.L., Ross, J.R.M., M.T., KELSO, E.J., WHITEHEAD, FREY, B.M. see BUHRER, M. GovEs, J.R., MCKENNA, B.J., E.M., ROMINGER, K.L. & FREY, F.J. see BUHRER, M. BLOMFIELD, I.A., BRAMLEY, RIDDELL, J.G. Effect of FROLICH, J.C. see RADERMACHER, J. K.W., SHARP, R.W., JONES, cimetidine and rifampicin on the FULLER, R.W. see CHOUDRY, N.B. D.F., HADLEY, R.J., BLYCHERT, metabolism of the specific FULLER, R.W. see EVANS, P.M. E., RICHARDSON, P.D.I., bradycardic agent, alinidine, FULLER, R.W. see SMITH, C. TIMERICK, S.J.B. & WATTS, D.A. 229P FULLINFAW, R.O. see MOULDS, A comparison of felodipine ER HARRON, D.W.G. see THAM, T.C.K. R.F.W. and nifedipine R as monotherapy HASINOFF, B.B. see CAMPBELL, in the treatment of essential N.R.C. GALIOTO, P. see PERUCCA, E. hypertension, 580P HASINOFF, B.B. see KARA, M. GALLAGHER, P.J., HENMAN, M.C., GOVES, J.R. see GOUDIE, A.W. HASSELSTROM, J. see YUE, Q.Y. COLEMAN, D.C., RUSSELL, R.J. GRAHAM, A. see PIRMOHAMED, M. HAVERICH, A. see STEINFATH, M. & SHANLEY, D.B. Antifungal GRAHAME-SMITH, D.G. see MORAES, HAWKESFORD, J.E. see SEYMOUR, drug sensitivity of Candida M.E.A. R.A. albicans from HIV positive GRAHNEN, A., WENNERLUND, P., HAYNES, W.G., CULLEN, M.J., patients, 234P DAHLSTROM, B. & ECKERNAS, WorsLEY, M.H. & WEBB, D.J. GANGJI, D. see HERCHUELZ, A. S.-A. Inter- and intraindividual Human skin responses to GAUDRIC, M. see KAHAN, A. variability in the concentration- intradermal injection of inhibitors GAZZAZ, J. see AL-EITHAN, M. effect (sedation) relationships of of the renin-angiotensin system, GE, J. see BARNES, N.M. flunitrazepam, 89 614P GEERTZ, B. see STEINFATH, M. GRAM, L.F. see WARD, S.A. HAYWARD, R.A. see CHALLENOR, GEMMILL, J.D., HoGG, K.J., BURNS, GRANT, A.C. see MACDONALD, N.J. V.F. J.M.A. RAE, A.P., DUNN, F.P., GRAY, P.L. see GOUDIE, A.W. HELLGREN, U. see ALVAN, G. FEARS, R., FERRES, H.., GRAY, S.J., GILES, H., PARKER, HELsBY, N.A. see WARD, S.A. STANDRING, R., GREENWOOD, J.E., PHILLIPS, $.C., BOLOFO, HENMAN, M.C., FERRANDO, C. & H., PIERCE, D. & HILLIs, W.S. M-L. & POSNER, J. Effect of CORRIGAN, O.I. Benzodiazepine A comparison of the prostaglandin DP-receptor partial prescribing and utilization trends pharmacokinetic properties of agonist (192C86) on platelet in Ireland, 238P streptokinase and anistreplase in aggregation and the cardiovascular HENMAN, M.C. see GALLAGHER, acute myocardial infarction, 143 system in healthy volunteers, 226P P.J. GEMMILL, J.D., HoGG, K.J., GREENWOOD, H. see GEMMILL, J.D. HENNEN, J. & COHEN, A.F. MACINTYRE, P.D., KHOLEIF, M.., GRIB, C. see SOONS, P.A. Demonstration: Promasys—a BooTH, N., RAE, A.P., DUNN, GRIFFIN, M.J. see CHALLENOR, V.F. protocol management system for F.G. & HILLIs, W.S. Dose finding GRIFFITHS, T.L. see ROWLANDS, clinical studies, 616P with bolus dose alteplase in acute D.E. HERCHUELZ, A., GANGIJI, D., myocardial infarction, 574P GRIMM, T. see FEELY, J. DERENNE, F., JEANNOIT, J. Ph. & GENSINI, G.F. see MODESTI, P.A. GRUNDY, P.F. see DAVEY, N.B. DOUCHAMPS, J. Metabolism of GEORGE, C.F. see AHSAN, C.H. GUERRE, J. see KAHAN, A. almitrine in extensive and poor GEORGE, C.F. see ROBERTSON, GUMBLETON, M. & BENET, L.Z. metabolisers of debrisoquine/ DRE. Pharmacological activity of the sparteine, 73 GERLOFF, J. see DE BOER, A. dinitrate metabolites of HERKES, G.K. see HOOPER, W.D. GIANNI, A.A.G. see CONDINO-NETO, nitroglycerin following their oral HERVE, J.P. see ALLAIN, P. A. administration to healthy HERXHEIMER, A. see COLLIER, J. GIESCHIKHE, R. see VAN volunteers, 211 HIGGINSON, I. see ROBERTSON, STEVENINCK, A.L. GUMBLETON, M., VEROTTA, D. & D.R-C. GILES, H. see GRAY, S.J. BENET, L.Z. Non steady-state HILLIS, W.S. see GEMMILL, J.D. GILL, T.S. see BULLMAN, J.N. dose ranging pharmacodynamics HINRICHSEN, H., HALABI, A. & GIRBES, A.R.J., VAN VELDHUISEN, of the 1,3 dinitrate metabolite of KIRCH, W. Comparison of the D.J., SMIT, A.J., DRENT- glyceryl trinitrate in healthy haemodynamic effects of quinidine BREMER, A., MEIER, S. & volunteers, 597P and famotidine in patients with REITSMA, W.D. Renal and GUNZLER, W.A. see DE BOER, A. congestive heart failure, 571P neurohumoral effects of GupPTA, O.M. see GOUDIE, A.W. Ho, C.S. see CHAN, J.C.N. ibopamine and metoclopramide Guy, S. see THAM, T.C.K. Ho, C.S. see CHAN, T.Y.K. in normal man, 701 Gyr, K. see DREWE, J. HOEVERS, J.W. see SCHELLENS, GIUDICELLI, J.-F. see THUILLEZ, C. J.H.M. GIUDICELLI, J.-F. see UZZAN, B. HA, H.R. see FATTINGER, K. HOFFMAN, B.B. see FORD, G.A. GIULIANI, L. see TEMELLINI, A. HADLEY, R.J. see GOUDIE, A.W. HoaG, K.J. see GEMMILL, J.D. GJESDAL, K., KLEMSDAL, T.O., HAGEGE, H. see MAGUEUR, E. HOLGATE, S.T. see ROWLANDS, D.E. RYKKE, E.O. & BREDESEN, J.E. HALABI, A. see HINRICHSEN, H. HOLGATE, S.T. see SUMMERS, Q.A. Transdermal nitrate therapy: HAMADA, K. see SAKAI, H. HOLT, D.W. see FASHOLA, T.O.A. 730 Index HOLT, D.W. see MILLANE, T.A. JEANNOIT, J. Ph. see HERCHUELZ, A. KARHUVAARA, S., KALLIO, A., HONG, C-Y. see SHEN, M-R. JENTSCH, D. see RADERMACHER, J. SALONEN, M., TUOMINEN, J. & HOOGKAMER, J.F.W. see COHEN, JOANNE, C. see DUCHE, J-C. SCHEININ, M. Rapid reversal of A.F. JOHNSTON, A. see FASHOLA, T.O.A. a2-adrenoceptor agonist effects Hooper, W.D., KAVANAGH, M.C., JOHNSTON, A. see LLEDO, P. by atipamezole in human HERKES, G.K. & EADIE, M.J. JOHNSTON, G.D. see PASSMORE, volunteers, 160 Lack of a pharmacokinetic A.P. KARLSSON, K.K. see ALVAN, G. interaction between JOHNSTON, G.D., WILSON, R.E.A. & KAVANAGH, M.C. see HOOPER, phenobarbitone and gabapentin, McDERMOTT, B.J. A comparison W.D. 171 of the antihypertensive and KAYE, C.M. see BULLMAN, J.N. HorRTON, R. see HUCKER, R.S. metabolic effects of low and KECHRID, R. see THUILLEZ, C. HOWARD, P.J. see MCCLUNE, S. conventional cyclopenthiazide KEELING, P.W.N. see BARRY, M.G. HUCHET, B. see SOBHANI, I. during the second year of KEENE, O.N. see FRAZER, N.M. HuckER, R.S. see PEPPIATT, J.E. treatment, 246P KEENE, O.N. see MINTON, N.A. HUCKER, R.S., PEPPIATT, J.E., JONES, D.F. see GOUDIE, A.W. KERRY, R.J. see FRAZER, N.M. DAVIES, B.E., HORTON, R. & JONES, R.W., COLLINS, A.J., KELLY, D.E. see CHING, M.S. PRINCE, W.T. The NOTARIANNI, L.J. & SEDMAN, E. KELLY, S.L. see CHING, M.S. pharmacokinetics of BRL 42715 The comparative pharmacokinetics KELSO, E.J. see HARRON, D.W.G. following intravenous of acetametacin in young subjects KENNEDY, N. see MOTWANI, J.G. administration in man, 590P and elderly patients, 543 KENSINGTON, J.E. see MINTON, N.A. HUMPHRIES, S.J. see AIRD, S.A. JONES, R.W. see ELLMERS, S.E. KEys, J., LAU, C.S. & LANG, C.C. HUMPHRIES, S.J. see OLIVER, S.E. JONES, R.W. see WESNES, K. Non-steroidal anti-inflammatory HUSSAIN, F. see MORGAN, P. JONES, W.G. see BARNES, N.M. drugs—which, when and why? A JORGE, L.F. see ARIAS, T.D. survey amongst Tayside general IDZIKOWSKI, C., MILLS, F.J. & JORGENSEN, H.S., CHRISTENSEN, practitioners, 238P JAMES, R.J. A dose-response H.R. & KAMPMANN, J.P. KHOLEIF, M. see GEMMILL, J.D. study examining the effects of Interaction between digoxin and KING, A.R. see DICKINSON, R.G. ritanserin on human slow wave indomethacin or ibuprofen, 108 KING, D.J., BELL, P., BEST, S.J., sleep, 193 JUER, L. see WALLER, D.G. LOGUE, N. & BYTH, W. The IIDA, S. see SAKAI, H. McCollough effect as a measure of INABA, T. see TYNDALE, R.F. KAEWVICHIT, S. see WANWIMOLRUK, central cholinergic activity in man, IRVINE, N.A. see LIPWORTH, B.J. S. 239P ISLAM, S. see ALLAIN, P. KAHAN, A., CHAUSSADE, S., KING, D.J., BEST, S.J., IWANOV, V. & MOULDS, R.F.W. GAUDRIC, M., FREITAG, B., MONTGOMERY, R.C. & Differing calcium sensitivities of AMOR, B., MENKES, C.J., MANNION, M.F. A comparison of human cerebral and digital STRAUCH, G., GUERRE, J. & the effects of promethazine and arteries, human metatarsal veins, COUTURIER, D. The effect of lorazepam on saccadic eye and rat aorta, 47 cisapride on gastro-oesophageal movements and psychomotor dysfunction in systemic sclerosis: a performance, 239P JACK, D. A way of looking at controlled manometric study, 683 KING, D.J., BLOMOVIST, M.., agonism and antagonism: lessons KALHORN, T.F. see EPSTEIN, M.M. CoopPER, S.J., DOHERTY, M.M.., from salbutamol, salmeterol and KALLIO, A. see KARHUVAARA, S. MITCHELL, M.J. & other B-adrenoceptor agonists, KALOw, W. see TYNDALE, R.F. MONTGOMERY, R.C. Placebo- 501 KAMALI, F. see EDWARDS, C. controlled trial of remoxipride in JACKA, N. see MOULDS, R.F.W. KAMALI, F. see FERNER, R.E. the prevention of relapse in JACKSON, P.R., BoosBis, A.R. & KAMPMANN, J.P. see BONDE, J. chronic schizophrenia, 220P TUCKER, G.T. Letter to the KAMPMANN, J.P. see JORGENSEN, KIRBY, J. see WESNES, K. Editors: Phenotype or genotype?, HS. KIRCH, W. see BAMMEL, A. 119 KAPOUR, A. see ROWLANDS, D.E. KIRCH, W. see HINRICHSEN, H. JACKSON, P.R. see LEwis, R.V. KARA, M., HASINOFF, B.B., KIRCH, W. see SCHMITT, R. JACKSON, P.R., TUCKER, G.T. & McKay, D. W. & CAMPBELL, KIRCH, W. see SOONS, P.A. Woops, H.F. Backtracking booze N.R.C. Clinical and chemical KISSEL, T. see DREWE, J. with Bayes—the retrospective interactions between iron KJELDSEN, S. see MELLEM, H. interpretation of blood alcohol preparations and ciprofloxacin, KLEINBLOESEM, C.H., FAHRNER, E., data, 55 257 WEBER, C., DELLENBACH, M., JAMES, R.J. see IDZIKOWSKI, C. KARBWANG, J., MILTON, K.A., NA SCHROTER, V. & BELZ, G.G. JAMIESON, M.J., WEBSTER, J., BANGCHANG, K., WARD, S.A., Haemodynamics, biochemical FOWLER, G., RAWLES, J., SMITH, EDWARDS, G. & BUNNAG, D. effects and pharmacokinetics of F.W. & PETRIE, J.C. Plasma concentrations and the renin inhibitor Ro 42-5982 in A comparison of the chronic response to halofantrine in Thai healthy man, 588P effects of oral xamoterol and patients with acute uncomplicated KLEINBLOESEM, C.H. see SCHMITT, enalapril on blood pressure and falciparum malaria, 231P R. renal function in mild to moderate KARBWANG, J., MILTON, K.A., NA KLEINSBLOESEM, C.H. see VAN heart failure, 305 BANGCHANG, K., WARD, S.A., GRIENSVEN, J.M.T. JAMISON, J.P. & BRANNIGAN, P. EDWARDS, G. & BUNNAG, D. KLEMSDAL, T.O. see GJESDAL, K. Computer interactive video model Pharmacokinetics of halofantrine KLUFT, C. see DE BOER, A. of a cardiovascular case in Thai patients with acute KOBAYASHI, S. see SAKAI, H. presentation to teach clinical uncomplicated falciparum malaria, KOSTUK, W.J. see ARNOLD, J.M.O. observation, diagnosis and 484 KOYAMA, E. see KUBOTA, K. therapy, 248P KARBWANG, J. see NOSTEN, F. KRIVITZKY, A. see UZZAN, B. Index 731 KROEMER, H. see AYESH, R. combination, on psychometric BRADSHAW, C.M. Comparison of KROON, C., DE BOER, A., KROON, performance, 333 the effects of acute and chronic J.M., SCHOEMAKER, H.C., VAN LEIGH, T.J. see LINK, C.G.G. treatment with fluvoxamine on DER MEER, F.J.M. & COHEN, LENNARD, M.S. Leading article: peripheral B-adrenoceptor- A.F. Just a pinch more heparin. Clinical Pharmacology through the mediated responses in man, 575P Influence of skinfold thickness on looking glass: reflections on the LLEDO, P., ABRAMS, S.M.L., heparin absorption, 598P racemate vs enantiomer debate, JOHNSTON, A. & PEARSON, R.M. KROON, J.M. see KROON, C. 623 Mexiletine elimination and KROON, J.M. see VAN STEVENINCK, LENNARD, M.S. see CHING, M.S. debrisoquine hydroxylator status, Al. LENNARD, M.S. see LEwIs, R.V. 598P KROON, R. see COHEN, A.F. LENOX-SMITH, A.J. see SMITH, C. LLOYD, P. see LARKIN, J.G. KUBOTA, K., KOYAMA, E. & LEON, A. see UZZAN, B. Lo, H.B. see STEINFATH, M. YASUDA, K. Skin irritation LEUNG, S.K.F. see TOMLINSON, B. LODWICK, J. see FLEMING, P.F.J. induced by topically applied LEVIN, R. see SUMMERS, Q.A. LoFT, S. see SONNE, J. timolol, 471 Lewis, L.D., FITZGERALD, D.L., LOGUE, N. see KING, D.J. KUHLMANN, U. see MIKUS, G. MOHAN, P., THATCHER, N., LOwRIE, J.J. see LARKIN, J.G. KUITUNEN, T. see MATTILA, M.J. HARPER, P.G. & ROGERS, H.J. LUBEL, D. see DosBBs, R.J. KUMAR, S. see MCALEER, S.D. The pharmacokinetics of Lul, A.S. see ARNOLD, J.M.O. ifosfamide given as short and long LUSTINETZ, T. see RADERMACHER, J. LANDE, K. see MELLEM, H. intravenous infusions in cancer LANG, C.C. Enalapril blunts the patients, 77 antinatriuretic effect of Lewis, P.J. see PERUCCA, E. MACCLEAN, D. see YEO, W.W. noradrenaline in man, 569P LEwis, R., DURNIN, C., MCLAY, J., MACDONALD, N.J., GRANT, A.C., LANG, C.C. see KEYS, J. McEweENn, J. & McDEvitT, D.G. RODGER, R.S.C., MEREDITH, LANG, C.C., LAu, C.S., BELCH, J.J. Magnesium deficiency may be an P.A. & ELLIOTT, H.L. The effect & STRUTHERS, A.D. The effect of important determinant of of renal impairment on the atrial natriuretic factor on platelet ventricular ectopy in digitalised pharmacokinetics and metabolism function ex vivo in man, 243P patients with chronic atrial of bopindolol, 697 LANG, C.C., RAHMAN, A.R. & fibrillation, 200 MACDONALD, T.M. see BOATENG, STRUTHERS, A.D. Lithium does Lewis, R.V., RAMSAY, L.E.., Yih: not alter the natriuretic response JACKSON, P.R., YEO, W.W., MACFADYEN, R.J. see BAINBRIDGE, to a pressor dose of tyramine in LENNARD, M.S. & TUCKER, G.T. A.D. man, 587P Influence of debrisoquine MACFADYEN, R.J., BAINBRIDGE, LANG, C.C., RAHMAN, A.R. & oxidation phenotype on exercise A.D., LEES, K.R. & REID, J.L. STRUTHERS, A.D. Lithium does tolerance and subjective tolerance The response of first dose of an not alter the renal response to a and subjective fatigue after ACE inhibitor in essential pressor dose of tyramine in man, metoprolol and atenolol in healthy hypertension: a placebo controlled 705 subjects, 391 study utilising ambulatory blood LANT, A.F. see FEHER, M.D. LIGUORI, J. see MASSARELLA, J.W. pressure recording, 568P LANT, A.F. see NOORMOHAMED, LINK, C.G.G. see LEIGH, T.J. MACFADYEN, R.J., LEES, K.R. & F.B. LINK, C.G.G., LEIGH, T.J. & FELL, REID, J.L. Tissue and plasma LARKIN, J.G., MCKEE, P.W.J., G.L., Effects of granisetron and angiotensin converting enzyme FORREST, G., BEASTALL, G.H., lorazepam, alone and in and the response to ACE inhibitor PARK, B.K., LOWRIE, J.J., combination, on the EEG of drugs, | LLOYD, P. & BRODIE, M.J. Lack human volunteers, 93 MACHLEIDT, C. see MIKUS, G. of enzyme induction with LIPWORTH, B.J., IRVINE, N.A. & MACINTYRE, P.D. see GEMMILL, oxcarbazepine (600 mg) in healthy McDEVvITT, D.G. The effects of 3D subjects, 65 time and dose on the relative B- MACKLIN, B. see AHSAN, C.H. LAU, C.S. see KEYS, J. and B2-adrenoceptor antagonism MACKLIN, B.S. see ROBERTSON, LAU, C.S. see LANG, C.C. of betaxolol and atenolol, 154 D:R:€. LAVENDER, E.A. see CHOUDRY, LiPpwWORTH, B.J., IRVINE, N.A. & MACLEAN, D. see YEO, W.W. N.B. McDevitt, D.G. The effects of MACLENNAN, B.A. see THAM, LAWLOR, R. see MCCORMACK, time and dose on the relative B,/ Eek. P.M.E. B2-receptor antagonism of MACLEOD, A.P. see ARNOLD, LAWRENCE, G.P. see SCHOFIELD, betaxolol and atenolol, 221P J.M.O. P.M. LipwoRTH, B.J., IRVINE, N.A. & MACMATHUNA, P. see BARRY, M.G. LAwsON, M. see SALAS, I.G. McDEvIrTT, D.G. The effects of MACONOCHIE, J.G. see MINTON, LAWSON, M. see SALAS-HERRERA, chronic dosing on the relative B,/ N.A. I.G. B2-receptor antagonism of MADHI, A. see DUNDEE, J.W. LAWSON, R.S. see EDWARDS, B.D. betaxolol and atenolol, 223P MAGGs, J.L. see MORGAN, P. LAYNE, R.D. see ABATE, M.A. LIPWORTH, B.J., IRVINE, N.A. & MAGNA, L.A. see CONDINO-NETO, LEE, A. see BATEMAN, D.N. McDEvirTT, D.G. A dose-ranging A. LEE, M.R. see BOATENG, Y.A. study to evaluate the B- MAGUEUR, E., HAGEGE, H., LEE, P.S. see DAVEY, N.B. adrenoceptor selectivity of ATTALI, P., SINGLAS, E., LEEMAN, A.L. see BOWES, S.G. bisoprolol, 581P ETIENNE, J.P. & TABURET, A.M. LEES, K.R. see BAINBRIDGE, A.D. LIPWORTH, B.J. see RAHMAN, Pharmacokinetics of LEES, K.R. see MACFADYEN, R.J. A.R.A metoclopramide in patients with LEIGH, T.J., LINK, C.G.G. & FELL, LIPWORTH, B.J. see WHEELDON, liver cirrhosis, 185 G.L. Effects of granisetron and N.M. MANI, V. see RILEY, S.A. lorazepam, alone and in LISTER, B.S., SZABADI, E. & MANN, T.A.N. see CROME, R. 732 Index MANNION, M.F. see KING, D.J. McDEvITT, D.G. see LEWIS, R. MEREDITH, P.A. see MACDONALD, MANSOR, S.M. see EDWARDS, G. McDEvITT, D.G. see LIPWORTH, N.J. MANT, T. see ORME, M. B.J. MEREDITH, P.A., ELLIOTT, H.L., MARTIN, C. see ORME, M. McDEvITT, D.G. see RAHMAN, DONNELLY, R. & REID, J.L. MARTIN, F.I.R. see MOULDS, A.R.A. Prediction and optimisation of R.F.W. McDEVvITT, D.G. see WHEELDON, antihypertensive therapy with MARTIN, U., TEMPLE, R.M., N.M. enalapril and nifedipine, 224P WINNEY, R.J. & PRESCOTT, L.F. McDowWELL, J.F.W., SMYE, M., MERTINS, L. see BROCKMEYER, N.H. Cumulation of paracetamol and its TRINICK, T., SHORTT, J.A., MEVIO, E. see PERUCCA, E. metabolites during multiple dosing ARCHIBALD, M.P., TRIMBLE, MIHALY, G.W. see CHING, M.S. in patients with chronic renal E.R. & NICHOLLS, D.P. MIkus, G., MAST, V., FISCHER, C., failure, 566P Simvastatin in severe MACHLEIDT, C., KUHLMANN, U. MARTIN, U., WINNEY, R. & hypercholesterolaemia: a placebo & EICHELBAUM, M. PRESCOTT, L.F. Frusemide controlled trial, 340 Pharmacokinetics, bioavailability, disposition in patients on MCELNAY, J.C. see CAMPBELL, A.C. metabolism and acute and chronic continuous ambulatory peritoneal MCELNAY, J.C. see MCCALLION, hypertensive effects of dialysis (CAPD), 227P O.N.M. nitrendipine in patients with MASSARELLA, J.W., DEFEO, T.M., McEwEN, J. see LEwIs, R. chronic renal failure and moderate LIGUORI, J., PASSE, S. & McEwAN, J. see SMITH, C. to severe hypertension, 313 AOGAICHI, K. The effects of McEWAN, J.R. see CHOUDRY, N.B. MILLANE, T.A., FASHOLA, T. & cimetidine and ranitidine on the McGAVOCck, H. see MCCARTHY, Hor, D.W. The measurement of pharmacokinetics of cifenline, 481 M.D. magnesium in myocardial tissue, MAST, V. see MIKuS, G. MCGHEE, S.M. see BEVAN, E.G. 582P MATTILA, M.E. see MATTILA, M.J. McGRATH, K.M. see MOULDS, MILLAR, B.C., MCDERMOTT, B.J. & MATTILA, M.J., KUITUNEN, T. & R.F.W. PIPER, H.M. Functional MATTILA, M.E. Effects of alcohol MCINNES, G.T. see BEVAN, E.G. muscarinic acetylcholine receptors and two formulations of lorazepam MCINNES, G.T. see THOMSON, G.D. of the M>-subtypes in adult on the human skilled performance, McKay, D.W. Clinical and chemical ventricular cardiomyocytes, 245P 606P interactions between iron MILLAR, B.C., PIPER, H.M. & MAUNUKSELA, E.-L. see OLKKOLA, preparations and ciprofloxacin, McDERMOTT, B.J. Multiple sub- KT: 263 types of the NPY receptor in adult MAURAS, Y. see ALLAIN, P. McKay, D.W. see KARA, M. ventricular cardiomyocytes, 221P MCALEER, S.D., CHRYSTYN, H., MCKEE, P.W.J. see LARKIN, J.G. MILLAR, E. see ORME, M. KUMAR, S. & FEELY, M. MCKENNA, B.J. see GOUDIE, A.W. MILLS, F.J. see IDZIKOWSKI, C. Assessment of outpatient MCKILLopP, U.H. see YOUNG, I.S. MILTON, K.A. see KARBWANG, J. compliance and the R and S MCLAY, J. see LEwIs, R. MINERS, J.O. see BIRKETT, D.J. isomers of warfarin, 607P McLOUGHLIN, C.C., MIRAKHUR, MINERS, J.O. see DOECKE, C.J. MCCALLION, O.N.M., ADAIR, C.G., R.K., TRIMBLE, E.R. & CLARKE, MINTON, N.A., KENSINGTON, J.E., McELNAY, J.C., SCOTT, M.G., R.S.J. An in vitro model for MACONOCHIE, J.G. & KEENE, HAMILTON, B.A., MCCANN, J.P., studying suxamethonium-induced O.N. Does tachyphylaxis occur to STANFORD, C.F., NICHOLLS, C.F. muscle damage, 220P the non-pulmonary effects of & NICHOLLS, D.P. MCMAHON, M.T. see HARRON, salmeterol, 241P A pharmacokinetic comparison of D.W.G. MIRAKHUR, R.K. see MCLOUGHLIN, plain and enteric coated MCMANUS, M.E. see DOECKE, C.J. Ce. prednisolone tablets in patients MCMILLAN, C. see DUNDEE, J.W. MITCHELL, M.J. see KING, D.J. with COPD, 600P MCMILLAN, C.M. & DUNDEE, J.W. MITCHELL, R.H. see BALDERSON, McCANN, J.P. see MCCALLION, Problems of self-administration of D.E. O.N.M. P6 (Neiguan) antiemesis, 236P MODESTI, P.A., COLELLA, A., McCARTHY, M.D., WILSON-DAVIS, McCMuRRAY, J. & CHOPRA, M. CECIONI, I., GENSINI, G.F., K. & MCGAVockK, H. The Influence of ACE inhibitors on ABBATE, R. & NERI SERNERI, relationship between the number free radicals and reperfusion G.G. Acute reduction of TxA, of GP partners and the range of injury: pharmacological curiosity platelet binding sites after in vivo drugs prescribed by that practice, or therapeutic hope?, 373 administration of a TxA> receptor 176P MCNAMARA, P.J. see ZHANG, Y. inhibitor, 439 MCCLELLAND, G.R. see CROME, R. MEIER, R. see DREWE, J. MODIGLIANI, E. see UZZAN, B. McCLUNE, S., HOWARD, P.J., MEIJER, S. see GIRBES, A.R.J. MOHAN, P. see LEwis, L.D. Moore, J. & CLARKE, R.S.J. MELLEM, H., LANDE, K., KJELDSEN, MOLYNEAUX, M.E. see EDWARDS, Oral cimetidine premedication— S., WESTHEIM, A., EIDE, I., G. clinical onset of three peparations, EKHOLT, P.F. & BOYE, N.P. MONIG, H. see BAMMEL, A. 219P Faster and more reliable MONTGOMERY, R.C. see KING, D.J. McCorRMACK, P.M.E., LAWLOR, R., absorption of adrenaline by MoorE, J. see CARABINE, U.A. DONEGAN, C., WALSH, J.B., aerosol inhalation than by MOORE, J. see MCCLUNE, S. COAKLEY, D. & FEELY, J. Can subcutaneous injection, 677 Moore, U.J., SEYMOUR, R.A. & the elderly discriminate between MENKES, C.J. see KAHAN, A. RAWLINS, M.D. The efficacy of their medications? , 608P MEREDITH, P.A. see DONNELLY, R. locally applied aspirin and McDERMOTT, B.J. see JOHNSTON, MEREDITH, P.A. & ELLIOTT, H.L. paracetamol in postoperative pain, G.D. The application of concentration 615P McCDERMOTT, B.J. see MILLAR, B.C. effect modelling in the Moraes, M.E.A., ARONSON, J.K. & McDERMOTT, B.J. see THAM, development of a new GRAHAME SMITH, D.G. TCE. antihypertensive agent, 567P Intravenous strontium gluconate Index 733 as a kinetic marker for calcium in lipoxygenase inhibitor in healthy OLKKOLA, K.T. & MAUNUKSELA, healthy volunteers, 423 volunteers, 577P E.-L. The pharmacokinetics of MOREIRA, L. see SANTOS, S.R. NICHOLLS, C.F. see MCCALLION, postoperative intravenous MoRGAN, C.J.L. see DAVEY, N.B. O.N.M. ketorolac tromethamine in MorGAN, D.J. see CHING, M.S. NICHOLLS, D.P. see MCCALLION, children, 182 MORGAN, P., MAGGS, J.L., O.N.M. OMOSAKO, C. see SANTOS, S.R. HUSSAIN, F., PAGE, P.C.B. & NICHOLLS, D.P. see MCDOWELL, ORANRATNACHAI, A. see PARK, B.K. The effect of J.F.W. WANWIMOLRUK, S. fluorination on the metabolic NICHOLLS, D.P. see YOUNG, I.S. ORME, M. L’E. Book review: Animal activation of oestrogens to NICHOLLS, M.G. see CHAN, J.C.N. Toxicity Studies: Their Relevance potential carcinogens in vivo, 231P NICHOLSON, P.W. see BOWES, S.G. for Man, 494 MORLEY, M.J., BRADSHAW, NIELSEN, J.C., BJERRING, P. & ORME, M., BACK, D.J., TIA, J., C.M. & SZABADI, E. Effect of ARENDT-NIELSEN, L. MARTIN, C., MILLAR, E., MANT, clonidine and yohimbine on the A comparison of the hypoalgesic T. & MORRISON, P. The lack of pupillary light reflex and effect of paracetamol in slow- interaction between temafloxacin carbachol-evoked sweating in release and plain tablets on laser- and oral contraceptive steroids, healthy volunteers, 99 induced pain, 267 228P MORRISON, P. see ORME, M. NIHOYANNOPOULOUS, P. see BENITO- ORME, M., BACK, D.J., TWA, J., MOTWANI, J.G., FENWICK, M., ORFILA, M.A. MARTIN, C., MILLAR, E. & KENNEDY, N. & STRUTHERS, NOGUEIRA, E. see SANTOS, S.R. SALMON, P. The lack of A.D. What determines the acute NOORMOHAMED, F.H. & LANT, A.F. interaction between clarithromycin effects of ACE inhibition on renal Analysis of the natriuretic action and oral contraceptive steroids, sodium handling in chronic heart of a loop diuretic, piritanide, in 229P failure, 586P man, 463 OwENS, D.R. see PETHICA, B.D. MOTWANI, J.G. & STRUTHERS, A.D. NOSTEN, F., TER KUILE, F., Indomethacin augments CHONGSUPHAJAISIDDHI, T., NA PACIFICI, G.M. see TEMELLINI, A. angiotensin-II-induced BANGCHANG, K., KARBWANG, J. PAGE, M.A., BOUTAGY, J.S. & antinatriuresis and renal & WHITE, N.J. Mefloquine SHENFIELD, G.M. As creening test vasoconstriction in man, 587P pharmacokinetics and resistance to for slow metabolisers of MOULDS, R.F.W., FULLINFAW, children with acute falciparum tolbutamide, 649 R.O., BURY, R.W., PLEHWE, malaria, 556 PAGE, P.C.B. see MORGAN, P. W.E., JACKA, N., MCGRATH, NOTARIANNI, L.J. see AIRD, S.A. PAN, H.Y., TRISCARI, J., DEVAULT, K.M. & MARTIN, F.I.R. NOTARIANNI, L.J. see ELLMERS, S.E. A.R., SMITH, S.A., WANG- Ponalrestat does not cause a NOTARIANNI, L.J. see JONES, R.W. IVERSON, D., SWANSON, B.N. & protein binding interaction with NOTARIANNI, L.J. see OLIVER, S.E. WILLARD, D.A. Pharmacokinetic warfarin in diabetic patients, 715 NYBERG, G.F., TRAKHTENBROIT, interaction between propranolol MOULDS, R.F.W. see IWANOV, V. A.D., DEsIR, D. & ZOGHBI, and the HMG-CoA reductase MULPETER, K., SCOTT, K., W.A. Heart rate, blood pressure, inhibitors pravastatin and COAKLEY, D. & FEELY, J. Drug symptoms and electro- lovastatin, 665 binding and hypothermia, 591P cardiographic changes during PAPINI, O. see SANTOS, S.R. MUMFORD, J.P. see PERUCCA, E. infusion of adenosine in patients PARISH, R.C. & SPIVEY, C. Influence MUNZER, J. see DREWE, J. with suspected coronary heart of menstrual cycle phase on serum MURRAY, G.D. see THOMSON, G.D. disease, 572P concentrations of a,-acid NYGAARD, E. see BONDE, J. glycoprotein, 197 PARK, B.K. see COLEMAN, M.D. NA BANGCHANG, K. see KARBWANG, O’BRIEN, E. see Cox, J.P. PARK, B.K. see LARKIN, J.G. BR O’CONNOR, B.J. see EVANS, P.M. PARK, B.K. see MORGAN, P. NA BANGCHANG, K. see NOSTEN, F. O’CONNOR, P., COOKE, T. & FEELY, PARK, B.K. see PIRMOHAMED, M. NACLERIO, R.M. see PONGRACIC, J. HMG Co-A reductase inhibitors PARK, B.K. see TINGLE, M.D. J.A. and lipoprotein(a) in PARKER, J.E. see GRAY, S.J. NANDHA, K.A. see BENITO-ORFILA, hypercholesterolaemia, 245P PARKER, L.R.C. see ELLMERS, S.E. M.A. O’DRISCOLL, J. see EDWARDS, B.D. PASCHELKE, S. see BROCKMEYER, NATION, R.L. see EVANS, A.M. O’MALLEY, K. see Cox, J.P. N.H. NAYLOR, R.J. see BARNES, N.M. O’NEILL, C.J.A. see BOWES, S.G. PASSMORE, A.P., COPELAND, S., NEELY, J.L. see ABATE, M.A. O’NEILL, C.J.A. see DOBBS, R.J. PASSMORE, C.M. & JOHNSTON, NELSON, S.D. see EPSTEIN, M.M. O’SULLIVAN, G. see SMITH, M. G.D. Precision measurement of NERI SERNERI, G.G. see MODESTI, ODLIND, B. see ALVAN, G. renal plasma flow and glomerular PA. OHNHAUS, E.E. see BAMMEL, A. filtration rate using single NESBIT, M.R. see SUMMERS, Q.A. OLIVER, R.M., FLEMING, J.S. & intravenous injection of PAH and NEUVONEN, P.J. The effect of WALLER, D.G. Xamoterol inulin in subjects with normal magnesium hydroxide on the oral improves right ventricular systolic renal function, 237P absorption of ibuprofen and and diastolic function in PASSMORE, C.M. see CAMPBELL, diclofenac, 263 pulmonary heart disease, 570P A.C. NEWCOMBE, R.G. see BAKER, D. OLIVER, S.E., AIRD, S.A., BELK, PASSMORE, C.M. see PASSMORE, NEWNHAM, D.M. see WHEELDON, D., HUMPHRIES, S.J., A.P. N.M. NOTARIANNI, L.J. & BENNETT, PAULA, M.L.L. see SANTOS, S.R. NEWTON, K. see PULLAR, T. P.N. Caffeine metabolism in PEARSON, R.M. see LLEDO, P. NICHOLLS, A.J. & POSNER, J. patients with carcinoma of the PEARSON, R.M. see SALAS- Investigation of single doses of lung, head and neck and ina HERRERA, I.G. BWAAC, a healthy selective 5- control population, 600P PEDERSEN, L.E. see BONDE, J. 734 Index PEPPER, J.R. see FASHOLA, T.O.A. K., TOOTHILL, C. & WRIGHT, V. RICHARDSON, P.D.I. see GOUDIE, PEPPIATT, J.E. see HUCKER, R.S. A study of adjunctive copper A.W. PEPPIATT, J.E., HUCKER, R.S. & sulphate treatment in patients with RICHARDSON, P.J. see YEO, W.W. DAVIE, B.E. A specific h.p.l.c. rheumatoid arthritis who have RICHER, C. see THUILLEZ, C. method for the determination of relapsed while taking RIDDELL, J.G. see HARRON, D.W.G. BRL 412715 in human plasma and p-penicillamine, 105 RIDDELL, J.G. see THAM, T.C.K. urine, 589P PUSSARD, E. see THUILLEZ, C. RILEY, S.A., TAVARES, I.A., PEREIRA, M.D. see SANTOS, S.R. PUSSARD, E. see UZZAN, B. BENNETT, A. & MANI, V. Effects PERRET, G. see UZZAN, B. of dietary fibre manipulation on PERUCCA, E., MEVIO, E., GALIOTO, the steady state kinetics of delayed P., BEcK, S.C., LEwIs, P. J. & RADERMACHER, J., JENTSCH, D., response mesalazine in patients MUMFORD, J.P. A single-blind SCHOLL, M.A., LUSTINETZ, T. & with ulcerative colitis, 599P trial of vigabatrin in tinnitus, 607P FROLICH, J.C. Diclofenac ROATH, O.S. see CHALLENOR, V.F. PETHICA, B.D. & OwENS, D.R. The concentrations in synovial fluid ROBERTS, D.E. see BAKER, D. first dose effect of an ACE and plasma after cutaneous ROBERTS, P. see PIRMOHAMED, M. inhibitor, 587P application in inflammatory and ROBERTSON, D.R.C., HIGGINSON, I., PETHICA, B.D. & OWENS, D.R. Use degenerative joint disease, 539 MACKLIN, B.S., RENWICK, A.G., of an integrated clinical trials RAE, A.P. see GEMMILL, J.D. WALLER, D.G. & GEORGE, C.F. database for the assessment of the RAHMAN, A.R. see LANG, C.C. The influence of protein unwanted effects of benazepril (an RAHMAN, A.R.A., MCDEVITT, containing meals on the ACE inhibitor) in hypertensive D.G., STRUTHERS, A.D. & pharmacokinetics of levodopa in patients, 612P LIPWORTH, B.J. The effect of healthy volunteers, 413 PETRIE, J.C. see BOATENG, Y.A. enalapril and spironolactone on RODGER, R.S.C. see MACDONALD, PETRIE, J.C. see JAMIESON, M.J. terbutaline-induced hypokalaemia, N.J. PHILLIPS, S.C. see GRAY, S.J. S7iIP ROGER, R.A. see DAVEY, N.B. PIERCE, D. see GEMMILL, J.D. RAKSHI, K. see FOSTER, R.W. ROGERS, H.J. see LEwis, L.D. PIETERS, M.S.M., SCHOEMAKER, RAMBAUD, J.C. see SOBHANI, I. ROMINGER, K.L. see HARRON, H.C., BREIMER, D.D. & COHEN, RAMSAY, J.D. & WOOLLEY, J.M. D.W.G. A.F. Is the healthy volunteer Demonstration of tablet and Ross, J.R.M. see GOUDIE, A.W. ‘normal’? A personality study of capsule identification using expert ROWLANDS, D.E., GRIFFITHS, T.L., volunteers participating in system and interactive video KaApour, A. & HOLGATE, S.T. pharmacological research, 611P techniques on an IBM PC Effect of adenosine on ventilation PIETERS, M.S.M. see VAN compatible computer, 612P under conditions of hypoxia, STEVENINCK, A.L. RAMSAY, L.E. see BRAWN, L.A. normoxia and hyperoxia, 573P PIPER, H.M. see MILLAR, B.C. RAMSAY, L.E. see FOSTER, G. RubDD, J.A. see BARNES, N.M. PIRMOHAMED, M., COLEMAN, RAMSAY, L.E. see LEWIs, R.V. RUDLAND, P.S. see WILD, M.J. M.D., BRECKENRIDGE, A.M. & RAMSAY, L.E. see TONER, J.M. RUSSELL, R.J. see GALLAGHER, P.J. PARK, B.K. The role of RAMSAY, L.E. & TUCKER, G.T. RYKKE, E.O. see GJESDAL, K. metabolism in sulphasalazine Editorial: The Journal in the mediated toxicity, 593P 1990s, 619 PIRMOHAMED, M., GRAHAM, A., RAMSAY, L.E. see YEO, W.W. SAKAI, H., KOBAYASHI, S., ROBERTS, P., SMITH, D., RAMSING, T. see BONDE, J. HAMADA, K., IIDA, S., AKITA, CHADWICK, D. C., RASMUSSEN, H.S. see SEDGWICK, M. H., TANAKA, E., UCHIDA, E. & BRECKENRIDGE, A.M. & PARK, RASMUSSEN, H.S. see THAM, T.C.K. YASUHARA, H. The effects of B.K. Use of an in vitro RAWLES, J. see JAMIESON, M.J. diltiazem on hepatic drug lymphocyte cytotoxicity assay to RAWLINS, M.D. Book Review: metabolizing enzymes in man assess the effects of carbamazepine European Pharmaceutical Policies using antipyrine, trimethadione (CBZ), phenytoin (DPH) and — Comparative Study, 124 and debrisoquine as model oxcarbazepine (OXCZ) in RAWLINS, M.D. see BATEMAN, D.N. substrates, 353 carbamazepine-hypersensitive RAWLINS, M.D. see EDWARDS, C. SALAS, I.G., LAWSON, M., TURNER, patients, 218P RAWLINS, M.D. see FERNER, R.E. P., Gott, D.M., DENNIS, M.J. & PLAYFORD, R.J. see BENITO-ORFILA, RAWLINS, M.D. see MOORE, U.J. WILLARS, J. Plasma M.A. REID, J.L. see BAINBRIDGE, A.D. metronidazole concentrations after PLEHWE, W.E. see MOULDS, R.F.W. REID, J.L. see DONNELLY, R. vaginal pessary administration, POND, S.M. see DICKINSON, R.G. REID, J.L. see MACFADYEN, R.J. 234P POND, S.M. see DOECKE, C.J. REID, J.L. see MEREDITH, P.A. SALAS-HERRERA, I.G., LAWSON, M. PONGRACIC, J.A., NACLERIO, R.M., REITSMA, W.D. see GIRBES, A.R.J. & PEARSON, R.M. The influence REYNOLDS, C.J. & PROUD, D. RENWICK, A.G. see AHSAN, C.H. of the oral contraceptive pill on A competitive kinin receptor RENWICK, A.G. see ROBERTSON, concentrations of albumin and a,- antagonist, [Darg’,Hyp* ,DPhe’]- D:R:¢C. acid glycoprotein in human bradykinin, 287 RESIFO, A.C. see DICKINSON, R.G. cervical mucus at mid-cycle, 592P POSNER, J. see GRAY, S.J. REUPCKE, C. see STEINFATH, M. SALMON, P. see ORME, M. POSNER, J. see NICHOLLS, A.J. REYNOLDS, C.J. see PONGRACIC, SALONEN, M. see KARHUVAARA, S. POZENEL, H. see SCHMITT, R. J.A. SANSOM, L.N. see DOECKE, C.J. PREHAR, S. see DASHWOOD, M.R. REYNOLDS, F. see SMITH, M. SANSOM, L.M. see EVANS, A.M. PREMEL-CABIC, A. see ALLAIN, P. REYNOLDS, G. see CHEN, Z.R. SANTOS, S.R., STORPIRTIS, S., PRESCOTT, L.F. see MARTIN, U. RIBEIRO, J.D. see CONDINO-NETO, PAPINI, O., OMOSAKO, C., PRINCE, W.T. see HUCKER, R.S. A. PAULA, M.L.L. & CAPACCI, L. PROUD, D. see PONGRACIC, J.A. RICHARDSON, P.D.I. see DAVEY, Plasma concentrations and urinary PULLAR, T., WRIGLEY, H., NEWTON, N.B. excretion of antipyrine and its